Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Injection Frequency and Differences in Visual Outcomes based on Diagnosis Year in Neovascular Age-related Macular Degeneration: Kyoung Hae Kang, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2024;65(2):117-124. Published online February 15, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.2.117; Full text PubReader ePub PDF

Efficacy of Injection Interval Shortening in Neovascular Age-related Macular Degeneration with Limited Response to Bimonthly Aflibercept: Min Chul Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2023;64(8):700-708. Published online August 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.8.700; Full text PubReader ePub PDF

Long-term Outcomes of Myopic Choroidal Neovascularization and Retinal Changes according to ATN Classification: Sujin Yeo, Jong Min Kim; J Korean Ophthalmol Soc. 2023;64(6):514-521. Published online June 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.6.514; Full text PubReader ePub PDF

Case Reports

Recurrent Idiopathic Choroidal Neovascularization in an Adolescent: Hayoung Lee, Jaehyuk Lee, Jongwon Moon; J Korean Ophthalmol Soc. 2023;64(2):158-163. Published online February 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.2.158; Full text PubReader ePub PDF

Original Articles

Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept: Daeun Shin, Jae Hui Kim; J Korean Ophthalmol Soc. 2022;63(6):526-534. Published online June 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.6.526; Full text PubReader ePub PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Diagnostic Availability of Optical Coherence Angiography in Type 1 and 2 Choroidal Neovascularization: Da Yeong Kim, Ki Seok Kim, Jie Hyun Youm; J Korean Ophthalmol Soc. 2021;62(3):345-353. Published online March 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.3.345; Full text PubReader ePub PDF

Clinical Outcomes after Switching from As-needed to Proactive Injections in the Neovascular Age-related Macular Degeneration: Soo Hyun Lim, Jae Hyung Hwang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jae Hui Kim; J Korean Ophthalmol Soc. 2020;61(6):630-638. Published online June 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.6.630; Full text PubReader ePub PDF

Case Reports

Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary to Optic Nerve Head Drusen.: Ka Hee Park; J Korean Ophthalmol Soc. 2019;60(12):1369-1373. Published online December 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.12.1369; PDF

Choroidal Neovascularization in a Patient with Best Disease.: Jae Uk Jung, Yu Min Kim, Yong Koo Kang, Dong Ho Park, Jae Pil Shin; J Korean Ophthalmol Soc. 2019;60(8):808-815. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.808
Web of Science 1 Crossref 1; PDF

Original Articles

Long-term Treatment Outcomes of Intravitreal Bevacizumab Treatment for Myopic Choroidal Neovascularization.: Jeong Min Lee, Jong Woo Kim, Dong Won Lee, Jae Hui Kim; J Korean Ophthalmol Soc. 2019;60(6):547-554. Published online June 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.6.547
Web of Science 2 Crossref 5; PDF

Clinical Presentations of Focal Choroidal Excavation and Results of Long-term Follow-up.: Seok Hyun Lee, Jae Hui Kim, Jong Woo Kim et al.; J Korean Ophthalmol Soc. 2019;60(6):541-546. Published online June 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.6.541
Web of Science 1 Crossref 5; PDF

Influence of Axial Length on Recurrence of Wet Age-related Macular Degeneration after Initial Treatment.: Soo Yeon Cho, Youn Gon Lee, Sang Yun Han et al.; J Korean Ophthalmol Soc. 2019;60(1):47-54. Published online January 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.1.47; PDF

Intravitreal Anti-vascular Endothelial Growth Factor Injections to Treat Neovascular Age-related Macular Degeneration: Long-term Treatment Outcomes.: Yu Jeong Park, Gi Sung Son, Yoon Jeon Kim, June Gone Kim, Young Hee Yoon, Joo Yong Lee; J Korean Ophthalmol Soc. 2018;59(12):1142-1151. Published online December 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.12.1142
Web of Science 1 Crossref 5; PDF

Characteristics of Patients Older than 90 Years Diagnosed with Neovascular Age-related Macular Degeneration.: Youn Gon Lee, Sang Yun Han, Jae Wook Han et al.; J Korean Ophthalmol Soc. 2018;59(5):444-450. Published online May 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.5.444
Crossref 3; PDF

Volume 65, No. 4

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

4,575	Contact Lens-induced Acute Red Eye
5,983	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
2,805	Two Cases of Cataract after COVID-19 mRNA Vaccine Injection
1,737	Clinical Outcomes of ATOS-mediated SmartSight Lenticule Extraction
1,066	Novel Method Measuring Conjunctival Microvascular Blood Flow Velocity by Zoom-lens, Ultra-high-speed Camera Attached Slit-lamp Biomicroscope

Cited By 3	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
Cited By 2	Comparison of Anterior Segment Measurements between Scheimpflug-Placido Camera and New Swept-source Optical Coherence Tomography
Cited By 2	Interocular Difference of Axial Length, Anterior Chamber Depth, Keratometry, Corneal Astigmatism According to Axial Length
Cited By 2	Impact of Social Distancing and Personal Hygiene on the Prevalence of Epidemic Keratoconjunctivitis during the COVID-19 Pandemic
Cited By 2	Clinical Benefits of Amniotic Membrane Contact Lens

Editorial Office: SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520 Fax: +82-2-583-6521 E-mail: kos08@ophthalmology.org

Copyright © 2024 by Korean Ophthalmological Society.

prev

next